VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GNW
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GNWGenworth Financial, Inc.
$9.54$3.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksGNWQuarterly Financials

Genworth Financial, Inc. (GNW) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Genworth Financial, Inc. (GNW) quarterly income statement — complete revenue, gross profit & net income history

GNW Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue1.78B1.49B1.87B1.73B1.78B1.72B1.84B1.73B1.84B1.87B1.8B1.88B1.83B1.87B1.81B1.85B1.85B1.91B2.01B2.04B
Revenue Growth %-0.06%-13.3%1.57%-0.35%-3.58%-7.91%2.44%-7.57%0.99%-0.16%-0.55%1.08%-1.35%-2.09%-9.99%-9.11%-5.13%-12.21%-12.07%3.81%
Medical Costs & Claims01.18B1.74B1.65B1.63B1.7B1.69B1.6B1.6B2.1B1.71B1.64B1.62B1.61B1.6B1.6B1.58B1.45B1.66B1.68B
Medical Cost Ratio %0%79.17%93.11%95.25%91.9%98.72%91.7%92.09%86.66%112.19%95.06%87.57%88.5%85.8%88.51%86.31%85.14%75.8%82.65%82.21%
Gross Profit0311M129M82M144M22M153M137M246M-228M89M233M210M266M208M254M275M463M349M363M
Gross Margin %0%20.83%6.89%4.75%8.1%1.28%8.3%7.91%13.34%-12.19%4.94%12.43%11.5%14.2%11.49%13.69%14.86%24.2%17.35%17.79%
Gross Profit Growth %-100%1313.64%-15.69%-40.15%-41.46%109.65%71.91%-41.2%17.14%-185.71%-57.21%-8.27%-23.64%-42.55%-40.4%-30.03%10%31.16%-36.31%337.35%
Operating Expenses213M293M-35M-43M18M-33M-8M-6M10M-11M-1M12M1M6M-12M-6M-16M208M-24M43M
OpEx / Revenue %11.99%19.62%-1.87%-2.49%1.01%-1.92%-0.43%-0.35%0.54%-0.59%-0.06%0.64%0.05%0.32%-0.66%-0.32%-0.86%10.87%-1.19%2.11%
Depreciation & Amortization00000000000000000000
Combined Ratio %11.99%98.79%91.24%92.76%92.91%96.81%91.27%91.75%87.2%111.6%95%88.21%88.55%86.12%87.85%85.98%84.28%86.67%81.45%84.32%
Operating Income80M18M164M125M126M55M161M143M236M-217M90M221M209M260M220M260M291M255M373M320M
Operating Margin %4.5%1.21%8.76%7.24%7.09%3.19%8.73%8.25%12.8%-11.6%5%11.79%11.45%13.88%12.15%14.02%15.72%13.33%18.55%15.68%
Operating Income Growth %-36.51%-67.27%1.86%-12.59%-46.61%125.35%78.89%-35.29%12.92%-183.46%-59.09%-15%-28.18%1.96%-41.02%-18.75%24.89%-32.89%-29.89%310.26%
EBITDA80M44M191M151M152M82M189M173M266M-187M120M250M238M288M246M286M317M286M408M363M
EBITDA Margin %4.5%2.95%10.2%8.74%8.55%4.76%10.25%9.98%14.43%-10%6.67%13.33%13.03%15.38%13.59%15.42%17.13%14.95%20.29%17.79%
Interest Expense25M26M27M26M26M27M28M30M30M30M30M29M29M28M26M26M26M31M35M95M
Non-Operating Income0-26M-27M-26M-26M-27M-28M-30M-30M-30M-30M-29M-29M-28M-26M-26M-26M-31M-35M-43M
Pretax Income111M18M164M125M126M55M161M143M236M-217M90M221M209M260M220M260M291M255M373M320M
Pretax Margin %6.25%1.21%8.76%7.24%7.09%3.19%8.73%8.25%12.8%-11.6%5%11.79%11.45%13.88%12.15%14.02%15.72%13.33%18.55%15.68%
Income Tax31M4M9M35M36M20M40M32M66M-36M30M55M55M56M54M62M68M62M67M75M
Effective Tax Rate %27.93%22.22%5.49%28%28.57%36.36%24.84%22.38%27.97%16.59%33.33%24.89%26.32%21.54%24.55%23.85%23.37%24.31%17.96%23.44%
Net Income80M2M116M51M54M-1M85M76M139M-212M29M137M122M175M136M159M191M163M314M240M
Net Margin %4.5%0.13%6.19%2.95%3.04%-0.06%4.61%4.39%7.54%-11.34%1.61%7.31%6.68%9.34%7.51%8.57%10.32%8.52%15.61%11.76%
Net Income Growth %48.15%300%36.47%-32.89%-61.15%99.53%193.1%-44.53%13.93%-221.14%-78.68%-13.84%-36.13%7.36%-56.69%-33.75%2.14%-38.95%-24.88%154.42%
EPS (Diluted)0.120.010.280.120.13-0.000.200.170.31-0.470.060.290.120.350.200.310.290.320.610.47
EPS Growth %-7.69%-40%-29.41%-58.06%99.51%233.33%-41.38%158.33%-234.29%-70%-6.45%-58.62%9.38%-67.21%-34.04%-21.62%-38.46%-25.61%154.65%
EPS (Basic)0.120.010.290.120.13-0.000.200.170.31-0.470.060.290.130.350.210.310.290.320.620.47
Diluted Shares Outstanding393.7M396.4M413.3M417.5M422.9M431M435.8M440.7M450.3M449.4M466M478.1M500.1M503.2M509.4M514.2M517.4M515.6M514.2M515M